稳健医疗 - Financials

稳健医疗 — Financial Statements

Annual Quarterly

5 10 All

Income Statement

Balance Sheet

Cash Flow

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
+Revenue	9.0B	8.2B	11.4B	8.0B	12.5B
Revenue Growth %	9.7%	-27.9%	41.2%	-35.9%	--
Total Revenue	9.0B	8.2B	11.4B	8.0B	12.5B
Cost Of Revenue	4.7B	4.2B	6.0B	4.0B	5.1B
+Gross Profit	4.2B	4.0B	5.4B	4.0B	7.5B
Gross Margin %	47.3%	49.0%	47.4%	49.9%	59.6%
Total Operating Cost	8.2B	7.7B	9.5B	6.8B	8.1B
Selling Expenses	2.3B	2.1B	2.0B	2.0B	1.6B
Admin Expenses	674.0M	694.0M	634.0M	454.0M	437.0M
Rd Expenses	348.0M	322.0M	488.0M	298.0M	411.0M
Finance Expenses	-99.2M	-61.9M	-123.0M	-107.0M	219.0M
+Operating Income	915.0M	818.0M	2.0B	1.5B	4.5B
Operating Margin %	10.2%	10.0%	17.4%	18.4%	36.2%
Non Operating Income	11.9M	16.6M	10.6M	6.0M	4.2M
Non Operating Expenses	18.4M	84.7M	67.6M	18.9M	33.5M
Investment Income	75.4M	127.0M	51.5M	103.0M	21.6M
Fair Value Change Income	2.9M	46.7M	32.1M	58.5M	11.2M
Asset Disposal Income	5.9M	32.2M	3.7M	3.3M	9,800
Asset Impairment Loss	243.0M	394.0M	363.0M	101.0M	240.0M
Other Income	91.6M	101.0M	84.4M	102.0M	70.3M
Income Before Tax	908.0M	750.0M	1.9B	1.5B	4.5B
Income Tax	168.0M	121.0M	245.0M	225.0M	680.0M
+Net Income	741.0M	629.0M	1.7B	1.2B	3.8B
Net Margin %	8.3%	7.7%	14.7%	15.4%	30.5%
Net Income Attributable	695.0M	580.0M	1.7B	1.2B	3.8B
Minority Interest	45.3M	48.1M	23.6M	-1.9M	12.1M
Eps Basic	1.19	0.98	2.79	2.91	9.80
Eps Diluted	1.19	0.98	2.79	2.91	9.79

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
Cash And Equivalents	1.4B	4.7B	4.5B	4.3B	4.2B
Trading Financial Assets	2.9B	2.9B	4.4B	3.1B	4.1B
Accounts Receivable	981.0M	769.0M	933.0M	776.0M	844.0M
Notes Receivable	34.3M	43.0M	51.0M	--	--
Notes And Accounts Receivable	1.0B	812.0M	984.0M	776.0M	844.0M
Prepayments	107.0M	122.0M	229.0M	110.0M	124.0M
Inventory	2.0B	1.4B	1.6B	1.6B	1.2B
Total Current Assets	8.1B	10.6B	12.1B	10.3B	11.0B
Long Term Equity Investment	445.0M	20.9M	21.7M	16.9M	13.4M
Fixed Assets	--	2.7B	2.3B	1.5B	1.4B
Fixed Assets Total	3.4B	2.7B	2.3B	1.5B	1.4B
Construction In Progress	--	985.0M	765.0M	216.0M	61.4M
Construction In Progress Total	1.1B	985.0M	765.0M	216.0M	61.4M
Intangible Assets	1.1B	995.0M	1.0B	266.0M	208.0M
Long Term Deferred Expenses	144.0M	131.0M	133.0M	175.0M	121.0M
Total Non Current Assets	10.3B	6.6B	6.1B	2.9B	2.0B
Total Assets	18.4B	17.1B	18.3B	13.3B	13.0B
Short Term Borrowings	2.0B	1.5B	2.3B	--	150.0M
Accounts Payable	1.2B	1.1B	1.1B	735.0M	727.0M
Advance Receipts	--	--	--	--	--
Contract Liabilities	183.0M	193.0M	567.0M	341.0M	530.0M
Total Current Liabilities	5.3B	4.3B	5.5B	2.1B	2.4B
Long Term Borrowings	53.0M	170.0M	--	--	--
Total Non Current Liabilities	1.2B	731.0M	568.0M	505.0M	107.0M
Total Liabilities	6.5B	5.0B	6.1B	2.6B	2.5B
Paid In Capital	582.0M	594.0M	426.0M	426.0M	426.0M
Capital Reserve	3.4B	4.4B	4.5B	4.5B	4.5B
Surplus Reserve	420.0M	420.0M	420.0M	420.0M	420.0M
Retained Earnings	6.8B	6.6B	6.8B	5.5B	5.1B
Minority Equity	724.0M	577.0M	478.0M	12.2M	14.5M
Equity Attributable	11.2B	11.5B	11.7B	10.7B	10.5B
Total Equity	11.9B	12.1B	12.2B	10.7B	10.5B

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
Cash From Sales	10.0B	8.8B	12.3B	8.6B	13.1B
Tax Refunds Received	115.0M	79.7M	13.0M	62.7M	244.0M
Total Operating Cash Inflow	10.3B	9.1B	12.5B	8.8B	13.5B
Cash Paid For Goods	6.2B	5.1B	6.5B	5.2B	6.3B
Cash Paid To Employees	1.8B	1.8B	1.8B	1.3B	1.0B
Taxes Paid	415.0M	751.0M	724.0M	898.0M	819.0M
Total Operating Cash Outflow	9.1B	8.0B	9.6B	7.9B	8.7B
Operating Cash Flow	1.3B	1.1B	3.0B	872.0M	4.8B
Total Investing Cash Inflow	3.6B	6.6B	8.2B	7.5B	4.6B
Total Investing Cash Outflow	7.7B	5.6B	12.1B	7.0B	9.0B
Investing Cash Flow	-4.1B	1.0B	-3.8B	479.0M	-4.4B
Cash From Borrowings	1.8B	2.2B	2.3B	--	150.0M
Dividends And Interest Paid	413.0M	822.0M	401.0M	768.0M	102.0M
Debt Repayments	1.5B	2.8B	150.0M	150.0M	259.0M
Total Financing Cash Inflow	2.0B	2.3B	2.3B	--	3.7B
Total Financing Cash Outflow	2.5B	4.1B	1.2B	1.4B	395.0M
Financing Cash Flow	-478.0M	-1.8B	1.1B	-1.4B	3.3B
Net Change In Cash	-3.3B	307.0M	282.0M	-61.1M	3.7B
Ending Cash Balance	1.4B	4.7B	4.4B	4.1B	4.2B
Capex	901.0M	753.0M	1.2B	743.0M	573.0M